MX9602034A - Compuesto parecidos a retinoides. - Google Patents
Compuesto parecidos a retinoides.Info
- Publication number
- MX9602034A MX9602034A MX9602034A MX9602034A MX9602034A MX 9602034 A MX9602034 A MX 9602034A MX 9602034 A MX9602034 A MX 9602034A MX 9602034 A MX9602034 A MX 9602034A MX 9602034 A MX9602034 A MX 9602034A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- formula
- independently hydrogen
- compound
- nhcs
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 150000003254 radicals Chemical class 0.000 abstract 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- -1 -CONHRy Chemical group 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion se refiere a compuestos de formula (I); o a una sal no toxica farmacéuticamente aceptable, un éster fisiologicamente hidrolizable o un solvato de los mismos en el cual: X es -O-CO-, -NH-CO-, -CS-NH-, -CO-O, -CO-NH, -COS-, -SCO-, -SCH2-, -CH2-CH2-, -C=_C-, -CH2-NH-, -COCH2-, -NHCS-, -CH2S-, -CH2O-, -OCH2-, OCH2-, -NHCH2- o -CR5=CR6-; Rm y Rk son independientemente hidrogeno, halogeno, C1-6 alquilo, hidroxi, C1-6 alquiloxi o nitro; n es cero o uno; R4 es -(CH2)t-Y, C1-6 alquilo o C3-6 cicloalquilo; R1 es CO2Z, C1-6 alquilo, CH2OH, -CONHRy, o CHO; R2 Y R3 son independientemente hidrogeno o C1-6 alquilo; Ra y Rb son independientemente hidrogeno o C1-6 alquilo; pero cuando n es uno, Ra y Rb juntos forman un radical de la formula Y es naftilo o fenilo, y ambos radicales pueden estar opcionalmente sustituidos con uno a tres iguales o diferentes C1-6 alquilo o halogeno; Z es hidrogeno o C1-6 alquilo; R5, R6 y R7 son independientemente hidrogeno o C1-6 alquilo; y t es cero a seis. También proporcionados por esta invencion, están los métodos para prevenir y/o tratar tumores, artritis y desordenes de la piel no malignos que comprenden la administracion de un compuesto de formula (I) a un mamífero. Adicionalmente se proporciona una formulacion farmacéutica (composicion que comprende un compuesto de formula (I) mezclado con un excipiente (s) farmacéuticamente aceptable (a).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/464,186 US5648385A (en) | 1994-01-03 | 1995-06-05 | Retinoid-like compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9602034A true MX9602034A (es) | 1997-08-30 |
Family
ID=23842896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9602034A MX9602034A (es) | 1995-06-05 | 1996-05-29 | Compuesto parecidos a retinoides. |
Country Status (11)
| Country | Link |
|---|---|
| KR (1) | KR970000224A (es) |
| CN (1) | CN1144217A (es) |
| CZ (1) | CZ160996A3 (es) |
| HU (1) | HU218963B (es) |
| IL (1) | IL118528A (es) |
| MX (1) | MX9602034A (es) |
| NO (1) | NO305946B1 (es) |
| RU (1) | RU2163590C2 (es) |
| SG (1) | SG42412A1 (es) |
| TW (1) | TW418186B (es) |
| ZA (1) | ZA964264B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2178B1 (en) * | 1999-10-19 | 2003-04-23 | اف . هوفمان لاروش ايه جي | Treatment of invasive diseases, using selected anti-PAR materials |
| GB0215978D0 (en) * | 2002-07-10 | 2002-08-21 | Karobio Ab | Novel compounds |
| RU2274453C1 (ru) * | 2004-12-07 | 2006-04-20 | Алам Джан | Фармацевтическая композиция для стабилизации гемостаза и купирования патологических процессов в организме |
| CN112004798A (zh) * | 2019-01-07 | 2020-11-27 | 江苏凯迪恩医药科技有限公司 | 一种苯甲酰胺类化合物、中间体、制备方法及应用 |
| RU2714932C1 (ru) * | 2019-09-26 | 2020-02-21 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" | Средство, обладающее цитотоксической активностью |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU85558A1 (fr) * | 1984-09-28 | 1986-04-03 | Oreal | Nouveaux derives naphtaleniques a action retinoique,leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant |
-
1996
- 1996-05-15 TW TW085105756A patent/TW418186B/zh active
- 1996-05-27 ZA ZA9604264A patent/ZA964264B/xx unknown
- 1996-05-29 NO NO962168A patent/NO305946B1/no not_active IP Right Cessation
- 1996-05-29 MX MX9602034A patent/MX9602034A/es unknown
- 1996-06-02 IL IL11852896A patent/IL118528A/en active IP Right Grant
- 1996-06-03 CZ CZ961609A patent/CZ160996A3/cs unknown
- 1996-06-04 SG SG1996009977A patent/SG42412A1/en unknown
- 1996-06-04 HU HU9601518A patent/HU218963B/hu not_active IP Right Cessation
- 1996-06-04 RU RU96111015/04A patent/RU2163590C2/ru active
- 1996-06-05 CN CN96105345A patent/CN1144217A/zh active Pending
- 1996-06-05 KR KR1019960020024A patent/KR970000224A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| IL118528A (en) | 2001-04-30 |
| HU9601518D0 (en) | 1996-07-29 |
| CZ160996A3 (en) | 1997-02-12 |
| TW418186B (en) | 2001-01-11 |
| IL118528A0 (en) | 1996-06-02 |
| HUP9601518A2 (en) | 1997-05-28 |
| HUP9601518A3 (en) | 1997-06-30 |
| HU218963B (hu) | 2001-01-29 |
| RU2163590C2 (ru) | 2001-02-27 |
| NO305946B1 (no) | 1999-08-23 |
| CN1144217A (zh) | 1997-03-05 |
| NO962168D0 (no) | 1996-05-29 |
| KR970000224A (ko) | 1997-01-21 |
| ZA964264B (en) | 1997-11-27 |
| SG42412A1 (en) | 1997-08-15 |
| NO962168L (no) | 1996-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU690598B2 (en) | Retinoid-like compounds | |
| EA200100766A1 (ru) | Хинолин-2-он замещенные гетероарильные производные, используемые в качестве противоопухолевых агентов | |
| CA2083606A1 (en) | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
| PL306590A1 (en) | Substituted heterocyclic carboxylamides, method obtaining them and their application as therapeutic agents | |
| BRPI9909282A (pt) | compostos de éter aminociclohexílicos e usos dos mesmos. | |
| CA2089767A1 (en) | Pyridinyl thiadiazolyl- and oxadiazolyl derivatives | |
| PT928788E (pt) | Compostos farmaceuticamente activos | |
| IL83905A (en) | Substituted phenylalkylamines, their preparation and psychostimulating pharmaceutical compositions comprising same | |
| ES8303291A1 (es) | Un procedimiento para la preparacion de nuevos derivados de ariletanolamina. | |
| EP0467856A3 (en) | Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases | |
| MY111702A (en) | 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative | |
| ES8207180A1 (es) | Procedimiento de fabricacion de derivados de tetrahidro-5,67,7a 4h-tieno (3,2-c) piridinona-2 . | |
| MX9602034A (es) | Compuesto parecidos a retinoides. | |
| NZ332687A (en) | use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents | |
| UA41281C2 (uk) | Тіоксантенонові сполуки, фармацевтична композиція на їх основі з протипухлинною активністю | |
| AU557139B2 (en) | Nitrosourea derivatives | |
| DE69001004D1 (de) | Zusammensetzung gegen leberkrankheiten. | |
| MY102090A (en) | Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom | |
| ES555618A0 (es) | Un procedimiento para preparar derivados de tioimidazol | |
| AU2742288A (en) | Novel compound effective as cerebral insufficiency improver | |
| ZA846141B (en) | 3-aryl-3-pyrroline derivatives,process for the preparation thereof and their application for controlling cardiac and vascular diseases |